SCHEMBL3651441

SCHEMBL3651441

O=C(O)C1CCN(Cc2cccc(Nc3ncc(-c4ccc(OC(F)F)cc4)cn3)c2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.46
▸ BTK Q06187 2/20 0.46
▸ KMT2A Q03164 2/20 0.45
▸ CHRM4 P08173 1/20 0.45
▸ PRKAA2 P54646 3/20 0.43
▸ ACHE P22303 1/20 0.43
▸ ACKR3 P25106 3/20 0.42
▸ JAK2 O60674 1/20 0.41
▸ JAK3 P52333 1/20 0.41
▸ ULK1 O75385 2/20 0.41
▸ ULK2 Q8IYT8 2/20 0.41
▸ CCR3 P51677 1/20 0.41
▸ GFRA3 O60609 1/20 0.41
▸ RET P07949 1/20 0.41
▸ NUAK1 O60285 1/20 0.40
▸ MARK3 P27448 1/20 0.40
▸ SIK1 P57059 1/20 0.40
▸ PRKAA1 Q13131 1/20 0.40
▸ IKBKE Q14164 1/20 0.40
▸ MELK Q14680 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3647130 0.92 EGFR (0.45) EGFRBTKKMT2ACHRM4GFRA3
SCHEMBL3651887 0.89 PTK2 (0.47) KMT2ACHRM4PRKAA2JAK2JAK3
SCHEMBL3652226 0.87 EGFR (0.46) EGFRBTKKMT2ACHRM4GFRA3
SCHEMBL3647478 0.87 EGFR (0.44) EGFRBTKGFRA3RETMELK
SCHEMBL3646162 0.86 EGFR (0.50) EGFRBTK
SCHEMBL3652561 0.85 EGFR (0.40) EGFRBTKKMT2ACHRM4ACHE
SCHEMBL3650207 0.85 GPR6 (0.41) EGFRBTKKMT2ACHRM4ACHE
SCHEMBL13472160 0.85 ACP1 (0.47) EGFRBTKPRKAA2JAK2JAK3
SCHEMBL3646358 0.85 EGFR (0.43) EGFRBTKCHRM4GFRA3RET
SCHEMBL3650935 0.85 ACHE (0.40) EGFRBTKCHRM4ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101784530-A 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors IRM LLC 2010-07-21 — — CN claimed
EP-2190825-A1 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2010-06-02 — — EP claimed
WO-2009026276-A1 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2009-02-26 — — WO claimed
US-8293757-B2 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors IRM LLC (BM) 2012-10-23 — — US disclosed
US-8293757-B2 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors IRM LLC (BM) 2012-10-23 — — US disclosed
CN-101784530-A 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors IRM LLC 2010-07-21 — — CN disclosed
EP-2190825-A1 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2010-06-02 — — EP disclosed
WO-2009026276-A1 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2009-02-26 — — WO disclosed
WO-2009026276-A1 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2009-02-26 — — WO disclosed
Send feedback